0M3Q.LSE Zoetis Inc.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
19.0x
P/B
-
ROE
82.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0M3Q.LSE undervalued?

Graham number

The Graham number of Zoetis Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zoetis Inc. fundamental analysis

No fundamental analysis for Zoetis Inc. yet.

Zoetis Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also …

Full company profile